ECTE Share Price

Open 0.08 Change Price %
High 0.08 1 Day 0.00 0.00
Low 0.08 1 Week -0.02 -20.00
Close 0.08 1 Month -0.06 -42.86
Volume 33780 1 Year -1.17 -93.60
52 Week High 2.84
52 Week Low 0.00
ECTE Important Levels
Resistance 2 0.08
Resistance 1 0.08
Pivot 0.08
Support 1 0.08
Support 2 0.08
NASDAQ USA Most Active Stocks
ASTI 0.00 0.00%
FNFG 10.18 -0.20%
DELL 13.86 0.22%
RFMD 16.59 -2.07%
SIRI 5.02 -1.76%
RIMM 13.03 0.39%
BBEP 0.12 0.00%
GTAT 0.44 0.00%
SUSQ 14.20 -0.77%
INTC 37.43 1.35%
More..
NASDAQ USA Top Gainers Stocks
SPIR 0.02 100.00%
LOCM 0.09 50.00%
IFON 0.63 34.04%
WRES 0.09 28.57%
SMSI 1.13 28.41%
EXAS 30.14 26.64%
BSDM 0.62 26.53%
SNTA 0.34 25.93%
OTT 2.39 25.13%
OPHC 2.80 21.21%
More..
NASDAQ USA Top Losers Stocks
TXCC 0.01 -95.00%
HCIIP 10.10 -67.52%
CRMB 0.27 -57.81%
KIOR 0.03 -57.14%
LLEN 0.01 -50.00%
PGRX 0.03 -50.00%
OSH 0.26 -49.02%
OSH 0.26 -49.02%
SNCR 13.29 -46.02%
DVOX 0.05 -44.44%
More..

Echo Therapeutics, Inc. (NASDAQ: ECTE)

ECTE Technical Analysis 5
As on 27th Apr 2017 ECTE Share Price closed @ 0.08 and we RECOMMEND Strong Sell for LONG-TERM with Stoploss of 0.61 & Strong Sell for SHORT-TERM with Stoploss of 0.13 we also expect STOCK to react on Following IMPORTANT LEVELS.
ECTE Target for April
1st Target up-side 0.16
2nd Target up-side 0.18
3rd Target up-side 0.19
1st Target down-side 0.12
2nd Target down-side 0.1
3rd Target down-side 0.09
ECTE Other Details
Segment EQ
Market Capital 56570792.00
Sector Healthcare
Industry Drug Manufacturers - Major
Offical website http://www.echotx.com
ECTE Address
ECTE
8 Penn Center
1628 JFK Boulevard
Philadelphia, PA 19103
United States
Phone: 215-717-4100
ECTE Latest News
Interactive Technical Analysis Chart Echo Therapeutics, Inc. ( ECTE NASDAQ USA )
Java support must be enabled in order to display FnCharts.
You can download Java from http://www.java.com
Your Comments and Response on Echo Therapeutics, Inc.
ECTE Business Profile
Echo Therapeutics, Inc. (Echo) is a transdermal medical device company. The Company is developing Prelude SkinPrep System (Prelude) as a technology to allow for painless and skin permeation that enable both analyte extraction and needle-free drug delivery. The Company is developing its Symphony CGM System (Symphony) as a non-invasive, wireless continuous glucose monitoring (CGM) system for use in hospital critical care units and for people with diabetes. The Prelude SkinPrep System (Prelude), a component of its Symphony CGM System, allows for skin permeation that enables extraction of analytes such as glucose. Prelude�s platform skin preparation technology also allows for needle-free, transdermal drug delivery.